US › Healthcare

Evolent Health Inc (EVH)

US · Healthcare · Health Information Services

$3.11-0.96%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$496.2M
Revenue YoY
+2.6%
Net profit
$-26.6M
Profit YoY
+58.8%
EPS
$-0.02
EPS estimate
$0.05
Net margin
-5.4%

EPS came in at -0.02 against a street estimate of 0.05 — a miss of 136.8%.

Key statistics

Market cap
$347.6M
Forward P/E
19.3
P/B
0.88
Book value
$3.52
EPS (TTM)
$-4.68
52-week high
$10.08
52-week low
$2.10
50-day MA
$4.76
200-day MA
$4.14
Beta
0.77

Analyst view

Analysts rate Evolent Health Inc a strong buy (13 buy, 1 hold, 0 sell out of 14) with an average price target of $5.83.

Shareholding

Insiders
3.18%
Institutions
101.09%

Largest institutional holders

FundStake
BlackRock Inc9.68%
Cadian Capital Management LP9.61%
Morgan Stanley - Brokerage Accounts8.07%
UBS Group AG7.25%
Rubicon Founders LLC5.17%
Engaged Capital LLC4.95%
D. E. Shaw & Co LP4.83%
Vanguard Capital Management, LLC4.33%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Evolent Health Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.